Bono G, Verri A P, Merlo P, Mancuso A, Sinforiani E, Mazzella G L
Università di Pavia, Istituto Neurologico C. Mondino, Clinica Malattie Nervose e Mentali.
Minerva Med. 1988 Dec;79(12):1085-9.
A study on dapiprazole, a new psychotropic agent, in the treatment of patients during the alcohol withdrawal syndrome, is reported. On the basis of evaluations made on the severity of the physical and psychic symptoms of withdrawal, the conclusion is drawn that the new psychotropic agent, administered at gradually increasing doses of 40 to 90 mg/kg for 7 days, completely controls the clinical symptomatology at least in 70% of the cases treated.
本文报道了一项关于新型精神药物达哌拉唑治疗酒精戒断综合征患者的研究。根据对戒断时身体和精神症状严重程度的评估,得出结论:以40至90毫克/千克的剂量逐渐增加给药7天,这种新型精神药物至少能在70%的治疗病例中完全控制临床症状。